Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?

Over the past 15 years, there has been great interest in the potential to repurpose the diabetes drug, metformin, as a cancer treatment. However, despite considerable efforts being made to investigate its efficacy in a number of large randomised clinical trials in different tumour types, results hav...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	British journal of cancer Ročník 128; číslo 6; s. 958 - 966
Hlavní autori:	Lord, Simon R, Harris, Adrian L
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Nature Publishing Group 06.04.2023
Predmet:	Antidiabetics Breast cancer Cancer Cancer therapies Cell growth Chemotherapy Clinical trials Diabetes Diabetes mellitus Drug dosages Drug Repositioning Glucose Humans Hypoglycemic Agents - therapeutic use Insulin Kinases Metabolism Metabolites Metformin Metformin - therapeutic use Neoplasms - drug therapy Oncology Pharmacodynamics Radiation therapy Tumors
ISSN:	0007-0920, 1532-1827, 1532-1827
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!